Bonderman David's Form 4 filing
Amneal Pharmaceuticals, Inc. (AMRX) · filed Dec 14, 2022
- Accession no.
- 0001387131-22-012411
- Filed
- Dec 14, 2022, 5:01 PM ET
- Trade date
- Dec 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $9.10M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonderman DavidCIK 0000860866 | Other: Former 10% Owner |
| Coulter James GCIK 0001099776 | Other: Former 10% Owner |
| Winkelried JonCIK 0001366946 | Other: Former 10% Owner |
| TPG GP A, LLCCIK 0001903793 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Class A Common Stock | SSaleDisposed | −3,884,600 | $2.34 | −$9,095,402.44 | 12,328,767 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.